Research Triangle Park, N.C. (AP) _ GlaxoSmithKline, the world's second-largest drugmaker, says it is boosting production of antiviral medication as reports of swine flu grow. The London-based company says it is ramping up operations to be able to produce about 5 million packs of Relenza per month, but it will take 12 to 14 weeks to get to that level.
Relenza is one of two antiviral drugs that make up the U.S. Government's stockpile of 44 million courses of antiviral medication. The other drug is Tamiflu, made by Swiss drugmaker Roche.
Glaxo says in a statement it is in discussions with other drugmakers about further increasing its capacity. The company says it has also been in touch with health authorities on development of a vaccine.